dr. morris on bone biomarkers for radium-223 in prostate cancer
Published 7 years ago • 81 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
1:30
dr. morris on challenges of radium-223 treatment in prostate cancer
-
1:24
dr. morris on the next steps with bone biomarkers for prostate cancer
-
0:46
dr. morris on mechanism of action for radium-223
-
1:43
dr. morris on radium-223 plus docetaxel in patients with bone metastasis from crpc
-
1:05
dr. morris on novel approaches with radium-223 in mcrpc
-
3:56
bone-targeted therapy for prostate cancer: radium-223
-
1:48
dr. morris on biomarkers in prostate cancer trials
-
1:10
dr. dreicer on challenges of radium-223 in prostate cancer
-
15:05
radium-223 in bone-metastatic castration-resistant prostate cancer
-
9:54
radium-223 for treatment of prostate cancer
-
2:15
dr. george on the use of radium-223 in prostate cancer
-
3:47
bone-migrated prostate cancer and radium-223 therapy
-
13:09
radium-223 alone and with other agents for prostate cancer
-
5:07
optimizing therapy with radium-223 for prostate cancer
-
1:34
dr. michael j. morris on radium-223 combination options for mcrpc
-
1:37
dr. daniel george on the incorporation of radium-223 in advanced prostate cancer
-
17:19
radium-223 in advanced disease
-
2:10
radium-223 in men with bone mcrpc
-
2:14
radium-223 and metastatic prostate cancer